|
NUP62 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.436100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.228950E-01 |
| Normal-vs-Stage2 |
6.963900E-02 |
| Normal-vs-Stage3 |
2.012700E-04 |
| Normal-vs-Stage4 |
1.091050E-01 |
| Stage1-vs-Stage2 |
1.749030E-01 |
| Stage1-vs-Stage3 |
8.29290000000649E-05 |
| Stage1-vs-Stage4 |
2.288000E-01 |
| Stage2-vs-Stage3 |
1.454650E-01 |
| Stage2-vs-Stage4 |
6.050400E-01 |
| Stage3-vs-Stage4 |
5.607200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.157500E-03 |
| Normal-vs-AfricanAmerican |
3.143800E-02 |
| Normal-vs-Asian |
1.655830E-01 |
| Caucasian-vs-AfricanAmerican |
8.265200E-01 |
| Caucasian-vs-Asian |
3.167200E-01 |
| AfricanAmerican-vs-Asian |
3.161600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.348080E-02 |
| Normal-vs-Female |
2.18849999999993E-06 |
| Male-vs-Female |
5.246200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.627700E-02 |
| Normal-vs-Extreme_Weight |
1.775410E-01 |
| Normal-vs-Obese |
3.609500E-04 |
| Normal-vs-Extreme_Obese |
4.011800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.823750E-01 |
| Normal_Weight-vs-Obese |
1.824810E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.333800E-02 |
| Extreme_Weight-vs-Obese |
5.383200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.535160E-01 |
| Obese-vs-Extreme_Obese |
2.668400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.158910E-03 |
| Normal-vs-Age(41-60Yrs) |
5.52569999999752E-05 |
| Normal-vs-Age(61-80Yrs) |
7.210100E-02 |
| Normal-vs-Age(81-100Yrs) |
6.848400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.449500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.617400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.479000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.129950E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.075900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.843400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.638140E-02 |
| Normal-VS-Type2 PRCC |
1.368370E-02 |
| Normal-VS-KIRP CIMP |
6.075900E-03 |
| Normal-VS-Unclassified PRCC |
4.455700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.919000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.988400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.379900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.516000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.273600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.085240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.877830E-02 |
| Normal-vs-N1 |
2.229700E-04 |
| Normal-vs-N2 |
5.637500E-04 |
| N0-vs-N1 |
5.624800E-03 |
| N0-vs-N2 |
1.064350E-01 |
| N1-vs-N2 |
7.660800E-01 |
|
|
